NSAID PRIOR AUTHORIZATION IS COST EFFECTIVE, AHCPR-FUNDED STUDY OF TENNESSEE MEDICAID CONCLUDES; COMPUTER-BASED DUR SHOULD BE VALIDATED -- NEJM ARTICLE
Executive Summary
Prior authorization is a cost-effective strategy for managing use of nonsteroidal anti-inflammatory drugs, an AHCPR-funded study published in the New England Journal of Medicine June 15 concludes.